• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DAREA/DAPSA 评分在评估银屑病关节炎疾病活动度中的应用。

Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis.

机构信息

Second Department of Medicine, Hietzing Hospital, Vienna, Austria.

出版信息

Ann Rheum Dis. 2010 Aug;69(8):1441-7. doi: 10.1136/ard.2009.122259. Epub 2010 Jun 4.

DOI:10.1136/ard.2009.122259
PMID:20525844
Abstract

BACKGROUND AND OBJECTIVES

Instruments for measuring disease activity in psoriatic arthritis (PsA) are not yet firmly established, and most of the currently employed ones have been derived for rheumatoid arthritis. Some of these instruments are based on 28 joint counts, which do not capture joints frequently affected in PsA. Therefore, the reliability and validity of DAREA (for 'Disease Activity index for REactive Arthritis'), which was originally developed for reactive arthritis and employs a 66/68 joint count, was tested in patients with PsA.

METHODS

Trial data from the Infliximab Multinational Psoriatic Arthritis Controlled Trial were analysed. Results were then independently validated using an observational data set. DAREA was compared to other composite indices regarding correlations with core set variables, sensitivity to change and criterion validity.

RESULTS

Good correlation of the DAREA with single items of disease activity, other composite scores (r=0.6-0.9) and physical function (Health Assessment Questionnaire; r=0.5) was found. Likewise, DAREA was at least as sensitive to change as the other indices and more so in patients with distal interphalangeal joint involvement. Additionally, DAREA correlated well with radiographic changes.

CONCLUSION

The analyses of this study provide evidence of the utility and validity of the DAREA for PsA disease activity assessment. A second name should therefore be assigned to this score: DAPSA (for 'Disease Activity index for PSoriatic Arthritis').

摘要

背景与目的

用于测量银屑病关节炎(PsA)疾病活动度的工具尚未确定,目前使用的大多数工具都是根据类风湿关节炎衍生而来的。其中一些工具基于 28 个关节计数,但无法捕捉到 PsA 中经常受影响的关节。因此,最初为反应性关节炎开发的、采用 66/68 个关节计数的 DAREA(代表“反应性关节炎疾病活动指数”)的可靠性和有效性在 PsA 患者中进行了测试。

方法

分析英夫利昔单抗治疗多发性银屑病关节炎的多国临床试验数据。然后使用观察性数据集对结果进行独立验证。将 DAREA 与其他综合指标进行比较,评估其与核心指标变量的相关性、对变化的敏感性和标准效度。

结果

DAREA 与疾病活动的单个项目、其他综合评分(r=0.6-0.9)和身体功能(健康评估问卷;r=0.5)具有良好的相关性。同样,DAREA 对变化的敏感性至少与其他指标一样,在涉及远侧指间关节受累的患者中更为明显。此外,DAREA 与放射学变化也有很好的相关性。

结论

本研究的分析结果提供了 DAREA 用于评估 PsA 疾病活动度的有效性和有效性的证据。因此,应该给这个评分起一个新的名字:DAPSA(代表“银屑病关节炎疾病活动指数”)。

相似文献

1
Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis.DAREA/DAPSA 评分在评估银屑病关节炎疾病活动度中的应用。
Ann Rheum Dis. 2010 Aug;69(8):1441-7. doi: 10.1136/ard.2009.122259. Epub 2010 Jun 4.
2
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).英夫利昔单抗治疗银屑病关节炎皮肤和关节表现的持续获益:英夫利昔单抗多国银屑病关节炎对照试验(IMPACT)的结果
Arthritis Rheum. 2005 Apr;52(4):1227-36. doi: 10.1002/art.20967.
3
Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression.DAPSA(一种银屑病关节炎专用工具)的疾病活动状态与功能状态和结构进展具有相关性。
Ann Rheum Dis. 2017 Feb;76(2):418-421. doi: 10.1136/annrheumdis-2016-209511. Epub 2016 Jul 25.
4
Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?基于 28 个关节的改良银屑病关节炎疾病活动指数(DAPSA)能否充分评估银屑病关节炎患者的疾病活动度?
Ann Rheum Dis. 2018 Dec;77(12):1736-1741. doi: 10.1136/annrheumdis-2018-213463. Epub 2018 Sep 20.
5
Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial.在接受静脉注射戈利木单抗治疗的活动性银屑病关节炎患者中,根据复合指数定义的疾病活动度水平,影像学进展得到抑制:来自一项 3 期、双盲、安慰剂对照试验的结果。
Arthritis Res Ther. 2020 Mar 6;22(1):43. doi: 10.1186/s13075-020-2126-1.
6
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score.银屑病关节炎(PsA)的疾病活动度:使用 DAPSA 评分定义缓解和治疗成功。
Ann Rheum Dis. 2016 May;75(5):811-8. doi: 10.1136/annrheumdis-2015-207507. Epub 2015 Aug 12.
7
Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis.评估复合疾病活动指标在评估银屑病关节炎中的适宜性。
Ann Rheum Dis. 2010 Mar;69(3):546-9. doi: 10.1136/ard.2009.117945. Epub 2009 Sep 17.
8
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices.评估银屑病关节炎患者可接受的症状状态 (PASS):与疾病活动度和生活质量指标的相关性。
RMD Open. 2020 Mar;6(1). doi: 10.1136/rmdopen-2020-001170.
9
Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.根据不同的疾病活动定义评估银屑病关节炎的负担:比较最小疾病活动和银屑病关节炎疾病活动指数。
Arthritis Care Res (Hoboken). 2018 Dec;70(12):1764-1770. doi: 10.1002/acr.23571.
10
Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial.银屑病关节炎的综合疾病活动指标:基于古塞单抗在一项干预性 II 期试验中的疗效比较仪器性能。
Arthritis Care Res (Hoboken). 2020 Nov;72(11):1579-1588. doi: 10.1002/acr.24046.

引用本文的文献

1
Factors influencing the transition time from psoriasis to psoriatic arthritis: a real-world multicenter analysis.影响银屑病向银屑病关节炎转变时间的因素:一项真实世界多中心分析。
Rheumatol Int. 2025 Sep 9;45(9):225. doi: 10.1007/s00296-025-05984-3.
2
The relationship between vitamin D receptor (VDR) genomic polymorphisms, disease activity, and functional ability in patients with psoriatic arthritis.银屑病关节炎患者中维生素D受体(VDR)基因多态性、疾病活动度和功能能力之间的关系。
Clin Rheumatol. 2025 Sep 4. doi: 10.1007/s10067-025-07610-w.
3
Guselkumab Efficacy in Biologic-Naïve Participants with Psoriatic Arthritis and Severe Disease Activity: Post Hoc Analysis of a Phase 3 Study.
古塞库单抗在初治的银屑病关节炎及严重疾病活动患者中的疗效:一项3期研究的事后分析
Rheumatol Ther. 2025 Jul 21. doi: 10.1007/s40744-025-00777-3.
4
Measurement properties of disease activity instruments in peripheral spondyloarthritis: a post-hoc analysis of the CRESPA trial.外周型脊柱关节炎疾病活动度评估工具的测量属性:CRESPA试验的事后分析
RMD Open. 2025 Jul 15;11(3):e005525. doi: 10.1136/rmdopen-2025-005525.
5
Prevalence of Undiagnosed Inflammatory Bowel Disease in Spondyloarthritis Patients.脊柱关节炎患者中未确诊的炎症性肠病患病率
J Clin Med. 2025 Jun 27;14(13):4569. doi: 10.3390/jcm14134569.
6
Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study.脊柱关节炎患者疼痛、疲劳和总体评分的互换性——一项基于登记处的模拟研究
BMC Rheumatol. 2025 Jul 1;9(1):75. doi: 10.1186/s41927-025-00527-6.
7
Collecting patient-reported outcomes via the COTIDIANA smartphone app: a prospective validity study.通过COTIDIANA智能手机应用程序收集患者报告的结果:一项前瞻性效度研究。
RMD Open. 2025 Jun 27;11(2):e005730. doi: 10.1136/rmdopen-2025-005730.
8
The concordance of swelling/tenderness with ultrasound-detected inflammatory lesions in patients with psoriatic arthritis.银屑病关节炎患者中肿胀/压痛与超声检测到的炎性病变的一致性。
Front Immunol. 2025 May 30;16:1562996. doi: 10.3389/fimmu.2025.1562996. eCollection 2025.
9
A six-month weight loss intervention is associated with significant changes in serum biomarkers related to inflammation, bone and cartilage metabolism in obese patients with psoriatic arthritis and matched controls.一项为期六个月的减肥干预措施与银屑病关节炎肥胖患者及匹配对照组中与炎症、骨骼和软骨代谢相关的血清生物标志物的显著变化有关。
BMC Rheumatol. 2025 May 23;9(1):58. doi: 10.1186/s41927-025-00511-0.
10
DEUS Enthesitis Index (DEI): a new tool integrating ultrasound and clinical examination for enthesitis assessment in spondyloarthritis.DEUS附着点炎指数(DEI):一种整合超声检查与临床检查的新型工具,用于评估脊柱关节炎中的附着点炎。
RMD Open. 2025 Apr 28;11(2):e005496. doi: 10.1136/rmdopen-2025-005496.